Literature Archives

Patients diagnosed via cryobiopsy showed significantly better overall survival than those diagnosed via surgical lung biopsy (HR 0.436, 95% CI 0.197 to 0.963, P = 0.035), likely due to insufficient subpleural sampling. Therefore, cryobiopsy should be used as a complementary tool to surgical biopsy, and its limitations must be carefully addressed during multidisciplinary discussions.

Relevant for IP practitioners performing BAL and protected specimen brush procedures in the ICU.

Clinicians should suspect bronchial Dieulafoy's disease in patients with benign-appearing endobronchial lesions and avoid biopsy until vascular anomalies are excluded, while recognizing that bronchial artery embolization can provide lifesaving hemostasis.

Accelerometry is a meaningful prognostic marker in malignant pleural effusion, as patients in the high steps group had a significantly longer median overall survival of 18.9 months compared to 9.3 months in the low steps group (P < 0.001).

This document serves as the definitive standard of care for interventional pulmonologists performing EBUS-TBNA for lung cancer staging.

Clinicians should consider pulmonary toxocariasis in patients presenting with migratory infiltrates, unexplained eosinophilic pleural effusion, or lung nodules, noting that a review of 26 cases showed 23 percent occurred in immunocompromised states.

For interventional pulmonary practice, performing thoracentesis from the lower intercostal space yields significantly higher malignancy detection on cytology (88.9%) compared to the upper space (58.3%, p = 0.013), provided it is done under ultrasound guidance to ensure safety.

Clinicians should remain vigilant for late-onset pleural effusion as a rare immune-related adverse event during long-term immunotherapy, which can be successfully managed with corticosteroid therapy after ruling out malignancy and radiation-induced causes.

Through four survey rounds, the panel reached consensus on 31 statements out of 48 total evaluated, providing the first expert guidance to standardize contemporary best practices and safety considerations for peripheral lung cryobiopsy.

An international, multicenter study demonstrates that in-channel mediastinal cryobiopsy using a 1.1-mm cryoprobe and standardized tunneling is a safe and reproducible method for obtaining high-volume tissue cores across major echobronchoscope platforms.

While large national databases highlight macro-level shifts in procedural volume and stent selection, clinicians must interpret these trends cautiously since administrative coding lacks granular anatomical and procedural details. Interventional pulmonologists should use these insights to benchmark local practice against national standards and advocate for specialized, high-volume airway management.

Flexible bronchoscopy deployment of Amplatzer vascular plugs is a feasible, minimally invasive option for successfully closing bronchopleural fistulas (BPF) and resolving persistent air leaks in high-risk patients unfit for surgery.